ANDA 84648, held by Ivax Sub Teva Pharms. Methocarbamol.
As of Nov 14, 2026, ANDA 84648 (Methocarbamol), held by Ivax Sub Teva Pharms, was first approved by FDA on Mar 11, 1977, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 11, 1977 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Methocarbamol500MG ยท tablet;oral | Methocarbamol | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters